| Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy JA Gustafson, H Ghandehari Advanced drug delivery reviews 62 (15), 1509-1523, 2010 | 95 | 2010 |
| Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety NA Vitanza, AL Wilson, W Huang, K Seidel, C Brown, JA Gustafson, ... Cancer discovery 13 (1), 114-131, 2023 | 91 | 2023 |
| Macrophage silica nanoparticle response is phenotypically dependent HL Herd, KT Bartlett, JA Gustafson, LD McGill, H Ghandehari Biomaterials 53, 574-582, 2015 | 86 | 2015 |
| Gold nanorod mediated plasmonic photothermal therapy: A tool to enhance macromolecular delivery AJ Gormley, K Greish, A Ray, R Robinson, JA Gustafson, H Ghandehari International journal of pharmaceutics 415 (1-2), 315-318, 2011 | 85 | 2011 |
| Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression J Gustafson, K Greish, J Frandsen, J Cappello, H Ghandehari Journal of Controlled Release 140 (3), 256-261, 2009 | 85 | 2009 |
| Genetically engineered nanocarriers for drug delivery P Shi, JA Gustafson, JA MacKay International journal of nanomedicine, 1617-1626, 2014 | 72 | 2014 |
| A hybrid protein–polymer nanoworm potentiates apoptosis better than a monoclonal antibody SR Aluri, P Shi, JA Gustafson, W Wang, YA Lin, H Cui, S Liu, PS Conti, ... ACS nano 8 (3), 2064-2076, 2014 | 71 | 2014 |
| Silk‐elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors K Greish, J Frandsen, S Scharff, J Gustafson, J Cappello, D Li, ... The journal of gene medicine 12 (7), 572-579, 2010 | 67 | 2010 |
| A thermo-responsive protein treatment for dry eyes W Wang, A Jashnani, SR Aluri, JA Gustafson, PY Hsueh, F Yarber, ... Journal of controlled release 199, 156-167, 2015 | 64 | 2015 |
| Synthesis and characterization of a matrix-metalloproteinase responsive silk–elastinlike protein polymer JA Gustafson, RA Price, J Frandsen, CR Henak, J Cappello, ... Biomacromolecules 14 (3), 618-625, 2013 | 64 | 2013 |
| Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme− Prodrug therapy JA Gustafson, RA Price, K Greish, J Cappello, H Ghandehari Molecular pharmaceutics 7 (4), 1050-1056, 2010 | 57 | 2010 |
| Fabrication of highly uniform nanoparticles from recombinant silk-elastin-like protein polymers for therapeutic agent delivery R Anumolu, JA Gustafson, JJ Magda, J Cappello, H Ghandehari, ... Acs Nano 5 (7), 5374-5382, 2011 | 56 | 2011 |
| Preclinical evaluation of bispecific adaptor molecule controlled folate receptor CAR-T cell therapy with special focus on pediatric malignancies YJ Lu, H Chu, LW Wheeler, M Nelson, E Westrick, JF Matthaei, II Cardle, ... Frontiers in oncology 9, 151, 2019 | 51 | 2019 |
| Cell‐templated silica microparticles with supported lipid bilayers as artificial antigen‐presenting cells for T cell activation BR Olden, CR Perez, AL Wilson, II Cardle, YS Lin, B Kaehr, JA Gustafson, ... Advanced healthcare materials 8 (2), 1801188, 2019 | 44 | 2019 |
| Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery R Price, J Gustafson, K Greish, J Cappello, L McGill, H Ghandehari International journal of pharmaceutics 427 (1), 97-104, 2012 | 43 | 2012 |
| Multimeric disintegrin protein polymer fusions that target tumor vasculature SM Janib, JA Gustafson, RO Minea, SD Swenson, S Liu, MK Pastuszka, ... Biomacromolecules 15 (7), 2347-2358, 2014 | 19 | 2014 |
| Locoregional CAR T cells for children with CNS tumors: clinical procedure and catheter safety NA Vitanza, R Ronsley, M Choe, C Henson, M Breedt, ... Neoplasia 36, 100870, 2023 | 12 | 2023 |
| Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety. Cancer Discov. 2023; 13: 114–131. doi: 10.1158/2159-8290 NA Vitanza, AL Wilson, W Huang, K Seidel, C Brown, JA Gustafson, ... CD-22-0750, 0 | 10 | |
| Preclinical evaluation of bispecific adaptor molecule controlled folate receptor CAR-T cell therapy with special focus on pediatric malignancies. Front Oncol. 2019; 9: 151 YJ Lu, H Chu, LW Wheeler, M Nelson, E Westrick, JF Matthaei, II Cardle, ... Go to original source... Go to PubMed, 2019 | 5 | 2019 |
| 100 Drug-regulatable engineered T cells eliminate CD33+ and CD33ΔE2+ AML J Appelbaum, WH Leung, U Martin, K Oda, G Tampella, D Xia, J Zhang, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 2 | 2020 |
J. Andrew MacKayGavin Herbert Associate Professor of Pharmaceutical SciencesVerified email at usc.edu
